{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:34:03Z","timestamp":1792467243028,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Multiple groups have created clinical practice guidelines (CPGs) for the management of primary hyperparathyroidism (PHPT). This report provides a rigorous quality assessment using the Appraisal of Guidelines for Research &amp; Evaluation Instrument (AGREE II) to identify high-performing guidelines and areas for improvement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic review was conducted to isolate CPGs addressing the management of PHPT. Guideline data was extracted and quality ratings were assigned by four independent reviewers. Intraclass correlation coefficients (ICC) were calculated to ensure interrater reliability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twelve guidelines were assessed. The American Association of Endocrine Surgeons (AAES) guideline had the highest mean scaled score across all domains (73.6\u2009\u00b1\u200931.4%). No other published guideline achieved a \u201chigh\u201d quality designation. The highest scoring domain was \u201cclarity of presentation\u201d (mean 60.5\u2009\u00b1\u200926.5%). The lowest scoring domain was \u201capplicability\u201d (mean 19.8\u2009\u00b1\u200918.2%). Scoring reliability was excellent, with ICC\u2009\u2265\u20090.89 for all AGREE II 6 domains.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although several working groups have developed guidelines to address PHPT management, only those published by the AAES meet all methodologic quality criteria necessary to ensure incorporation of recommendations into clinical practice. Future guidelines would benefit from the development of tools, resources, monitoring criteria that enhance applicability.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-024-03790-8","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T06:02:12Z","timestamp":1711692132000},"page":"864-872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quality appraisal of clinical practice guidelines for the evaluation and management of primary hyperparathyroidism"],"prefix":"10.1007","volume":"85","author":[{"given":"Mandy K.","family":"Salmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-3859","authenticated-orcid":false,"given":"Christian G.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Xavier","family":"Barrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj V.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinggang J.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eesha","family":"Balar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Rajasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"issue":"2","key":"3790_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"M.D. Walker, S.J. Silverberg, Primary hyperparathyroidism. Nat. Rev. Endocrinol. 14(2), 115\u2013125 (2018). https:\/\/doi.org\/10.1038\/nrendo.2017.104","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"3790_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"M.W. Yeh, P.H. Ituarte, H.C. Zhou et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98(3), 1122\u20131129 (2013). https:\/\/doi.org\/10.1210\/jc.2012-4022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3790_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.suc.2021.12.009","volume":"102","author":"L Slattery","year":"2022","unstructured":"L. Slattery, J.P. Hunt, Contemporary management of primary hyperparathyroidism. Surg. Clin. North Am. 102(2), 251\u2013265 (2022). https:\/\/doi.org\/10.1016\/j.suc.2021.12.009","journal-title":"Surg. Clin. North Am."},{"key":"3790_CR4","doi-asserted-by":"publisher","first-page":"e1013","DOI":"10.1136\/bmj.e1013","volume":"344","author":"S Pallan","year":"2012","unstructured":"S. Pallan, M.O. Rahman, A.A. Khan, Diagnosis and management of primary hyperparathyroidism. BMJ 344, e1013 (2012). https:\/\/doi.org\/10.1136\/bmj.e1013","journal-title":"BMJ"},{"issue":"12","key":"3790_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2020.0538","volume":"323","author":"CY Zhu","year":"2020","unstructured":"C.Y. Zhu, C. Sturgeon, M.W. Yeh, Diagnosis and management of primary hyperparathyroidism. JAMA 323(12), 1186\u20131187 (2020). https:\/\/doi.org\/10.1001\/jama.2020.0538","journal-title":"JAMA"},{"issue":"1","key":"3790_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.surg.2018.04.088","volume":"165","author":"Y Assadipour","year":"2019","unstructured":"Y. Assadipour, H. Zhou, E.J. Kuo, P.I. Haigh, A.L. Adams, M.W. Yeh, End-organ effects of primary hyperparathyroidism: A population-based study. Surgery 165(1), 99\u2013104 (2019). https:\/\/doi.org\/10.1016\/j.surg.2018.04.088","journal-title":"Surgery"},{"issue":"12","key":"3790_CR7","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1245\/s10434-011-1744-x","volume":"18","author":"AL Amin","year":"2011","unstructured":"A.L. Amin, T.S. Wang, T.J. Wade, T.W. Yen, Normal PTH levels in primary hyperparathyroidism: Still the same disease? Ann. Surg. Oncol. 18(12), 3437\u20133442 (2011). https:\/\/doi.org\/10.1245\/s10434-011-1744-x","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"3790_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/s0004-27302010000200004","volume":"54","author":"JP Bilezikian","year":"2010","unstructured":"J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism. Arq. Bras. Endocrinol. Metab. 54(2), 106\u2013109 (2010). https:\/\/doi.org\/10.1590\/s0004-27302010000200004","journal-title":"Arq. Bras. Endocrinol. Metab."},{"issue":"8","key":"3790_CR9","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/jcm10081604","volume":"10","author":"K Dandurand","year":"2021","unstructured":"K. Dandurand, D.S. Ali, A.A. Khan, Primary hyperparathyroidism: A narrative review of diagnosis and medical management. J. Clin. Med 10(8), 1604 (2021). https:\/\/doi.org\/10.3390\/jcm10081604","journal-title":"J. Clin. Med"},{"issue":"11","key":"3790_CR10","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","volume":"103","author":"JP Bilezikian","year":"2018","unstructured":"J.P. Bilezikian, Primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 103(11), 3993\u20134004 (2018). https:\/\/doi.org\/10.1210\/jc.2018-01225","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3790_CR11","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1210\/jc.2010-1221","volume":"96","author":"M Peacock","year":"2011","unstructured":"M. Peacock, J.P. Bilezikian, M.A. Bolognese et al. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. J. Clin. Endocrinol. Metab. 96(1), E9\u2013E18 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1221","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3790_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211015965","volume":"12","author":"AK Islam","year":"2021","unstructured":"A.K. Islam, Advances in the diagnosis and the management of primary hyperparathyroidism. Ther. Adv. Chronic Dis. 12, 20406223211015965 (2021). https:\/\/doi.org\/10.1177\/20406223211015965","journal-title":"Ther. Adv. Chronic Dis."},{"key":"3790_CR13","unstructured":"Hyperparathyroidism (primary): diagnosis, assessment and initial management. 2019. National Institute for Health and Care Excellence: Guidelines"},{"issue":"10","key":"3790_CR14","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"J.P. Bilezikian, M.L. Brandi, R. Eastell et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561\u20133569 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1413","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3790_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4158\/EP.11.1.49","volume":"11","author":"Hyperparathyroidism AATFoP","year":"2005","unstructured":"Hyperparathyroidism AATFoP, The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr. Pr. 11(1), 49\u201354 (2005). https:\/\/doi.org\/10.4158\/EP.11.1.49","journal-title":"Endocr. Pr."},{"issue":"1","key":"3790_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"A.A. Khan, D.A. Hanley, R. Rizzoli et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos. Int 28(1), 1\u201319 (2017). https:\/\/doi.org\/10.1007\/s00198-016-3716-2","journal-title":"Osteoporos. Int"},{"issue":"5","key":"3790_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40618-015-0261-3","volume":"38","author":"C Marcocci","year":"2015","unstructured":"C. Marcocci, M.L. Brandi, A. Scillitani et al. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J. Endocrinol. Invest 38(5), 577\u2013593 (2015). https:\/\/doi.org\/10.1007\/s40618-015-0261-3","journal-title":"J. Endocrinol. Invest"},{"key":"3790_CR18","doi-asserted-by":"publisher","unstructured":"F. Milat, S.K. Ramchand, M. Herath et al. Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society. Clin Endocrinol (Oxf). 2021;https:\/\/doi.org\/10.1111\/cen.14659","DOI":"10.1111\/cen.14659"},{"key":"3790_CR19","doi-asserted-by":"publisher","unstructured":"J.A. Miller, J. Gundara, S. Harper et al. Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society. Clin. Endocrinol. (Oxf). 2021;https:\/\/doi.org\/10.1111\/cen.14650","DOI":"10.1111\/cen.14650"},{"issue":"2","key":"3790_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40618-013-0022-0","volume":"37","author":"L Rosato","year":"2014","unstructured":"L. Rosato, M. Raffaelli, R. Bellantone et al. Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB). J. Endocrinol. Invest 37(2), 149\u2013165 (2014). https:\/\/doi.org\/10.1007\/s40618-013-0022-0","journal-title":"J. Endocrinol. Invest"},{"issue":"6","key":"3790_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1590\/s0004-27302013000600002","volume":"57","author":"M Sociedade Brasileira de Endocrinolo","year":"2013","unstructured":"M. Sociedade Brasileira de Endocrinologia e, F. Bandeira, L. Griz et al. Diagnosis and management of primary hyperparathyroidism-a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq. Bras. Endocrinol. Metab. 57(6), 406\u2013424 (2013). https:\/\/doi.org\/10.1590\/s0004-27302013000600002","journal-title":"Arq. Bras. Endocrinol. Metab."},{"issue":"10","key":"3790_CR22","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1210\/jc.2014-2000","volume":"99","author":"R Udelsman","year":"2014","unstructured":"R. Udelsman, G. Akerstrom, C. Biagini et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3595\u20133606 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3790_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/intqhc\/mzi027","volume":"17","author":"J Vlayen","year":"2005","unstructured":"J. Vlayen, B. Aertgeerts, K. Hannes, W. Sermeus, D. Ramaekers, A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J. Qual. Health Care 17(3), 235\u2013242 (2005). https:\/\/doi.org\/10.1093\/intqhc\/mzi027","journal-title":"Int J. Qual. Health Care"},{"issue":"10","key":"3790_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"S.M. Wilhelm, T.S. Wang, D.T. Ruan et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 151(10), 959\u2013968 (2016). https:\/\/doi.org\/10.1001\/jamasurg.2016.2310","journal-title":"JAMA Surg."},{"issue":"7 Suppl","key":"3790_CR25","first-page":"2","volume":"35","author":"M Zini","year":"2012","unstructured":"M. Zini, R. Attanasio, R. Cesareo et al. AME position statement: primary hyperparathyroidism in clinical practice. J. Endocrinol. Invest 35(7 Suppl), 2\u201321 (2012)","journal-title":"J. Endocrinol. Invest"},{"issue":"12","key":"3790_CR26","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","volume":"63","author":"MC Brouwers","year":"2010","unstructured":"M.C. Brouwers, M.E. Kho, G.P. Browman et al. AGREE II: advancing guideline development, reporting and evaluation in health care. J. Clin. Epidemiol. 63(12), 1308\u20131311 (2010). https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.001","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"3790_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1210\/jc.2007-1907","volume":"93","author":"BA Swiglo","year":"2008","unstructured":"B.A. Swiglo, M.H. Murad, H.J. Schunemann et al. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J. Clin. Endocrinol. Metab. 93(3), 666\u2013673 (2008). https:\/\/doi.org\/10.1210\/jc.2007-1907","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3790_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","volume":"16","author":"SJ Silverberg","year":"2013","unstructured":"S.J. Silverberg, M.D. Walker, J.P. Bilezikian, Asymptomatic primary hyperparathyroidism. J. Clin. Densitom. 16(1), 14\u201321 (2013). https:\/\/doi.org\/10.1016\/j.jocd.2012.11.005","journal-title":"J. Clin. Densitom."},{"issue":"1","key":"3790_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"R.A. Wermers, S. Khosla, E.J. Atkinson et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J. Bone Min. Res 21(1), 171\u2013177 (2006). https:\/\/doi.org\/10.1359\/JBMR.050910","journal-title":"J. Bone Min. Res"},{"issue":"5","key":"3790_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.surg.2020.05.018","volume":"168","author":"EA Alore","year":"2020","unstructured":"E.A. Alore, N.N. Massarweh, D.J. Ramsey et al. Variation in surgical management of primary hyperparathyroidism in the US Department of Veterans Affairs healthcare system: A 15-year observational study. Surgery 168(5), 838\u2013844 (2020). https:\/\/doi.org\/10.1016\/j.surg.2020.05.018","journal-title":"Surgery"},{"issue":"6","key":"3790_CR31","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/SLA.0b013e31824dad7d","volume":"255","author":"MW Yeh","year":"2012","unstructured":"M.W. Yeh, J.E. Wiseman, P.H. Ituarte et al. Surgery for primary hyperparathyroidism: are the consensus guidelines being followed? Ann. Surg. 255(6), 1179\u20131183 (2012). https:\/\/doi.org\/10.1097\/SLA.0b013e31824dad7d","journal-title":"Ann. Surg."},{"issue":"Jan 1","key":"3790_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/SLA.0000000000002474","volume":"269","author":"EJ Kuo","year":"2019","unstructured":"E.J. Kuo, M.A. Al-Alusi, L. Du et al. Surgery for primary hyperparathyroidism: Adherence to consensus guidelines in an academic health system. Ann. Surg. 269(Jan 1), 158\u2013162 (2019). https:\/\/doi.org\/10.1097\/SLA.0000000000002474","journal-title":"Ann. Surg."},{"issue":"6","key":"3790_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2022.103606","volume":"43","author":"C Fritz","year":"2022","unstructured":"C. Fritz, E. De Ravin, N. Suresh, D. Romeo, M. Shah, K. Rajasekaran, Clinical practice guidelines for management of medullary thyroid carcinoma: An AGREE II appraisal. Am. J. Otolaryngol. 43(6), 103606 (2022). https:\/\/doi.org\/10.1016\/j.amjoto.2022.103606","journal-title":"Am. J. Otolaryngol."},{"issue":"4","key":"3790_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2022.103508","volume":"43","author":"NV Suresh","year":"2022","unstructured":"N.V. Suresh, E. De Ravin, L.X. Barrette et al. Quality appraisal of clinical practice guidelines for the use of radiofrequency ablation in the treatment of thyroid nodules and cancer. Am. J. Otolaryngol. 43(4), 103508 (2022). https:\/\/doi.org\/10.1016\/j.amjoto.2022.103508","journal-title":"Am. J. Otolaryngol."},{"issue":"2","key":"3790_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12020-018-1786-y","volume":"63","author":"X Song","year":"2019","unstructured":"X. Song, J. Wang, Y. Gao et al. Critical appraisal and systematic review of guidelines for perioperative diabetes management: 2011-2017. Endocrine 63(2), 204\u2013212 (2019). https:\/\/doi.org\/10.1007\/s12020-018-1786-y","journal-title":"Endocrine"},{"issue":"2","key":"3790_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12020-019-01898-w","volume":"65","author":"S Gitto","year":"2019","unstructured":"S. Gitto, S. Bisdas, I. Emili et al. Clinical practice guidelines on ultrasound-guided fine needle aspiration biopsy of thyroid nodules: a critical appraisal using AGREE II. Endocrine 65(2), 371\u2013378 (2019). https:\/\/doi.org\/10.1007\/s12020-019-01898-w","journal-title":"Endocrine"},{"issue":"1","key":"3790_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12020-018-1535-2","volume":"60","author":"Y Fang","year":"2018","unstructured":"Y. Fang, L. Yao, J. Sun et al. Appraisal of clinical practice guidelines on the management of hypothyroidism in pregnancy using the Appraisal of Guidelines for Research and Evaluation II instrument. Endocrine 60(1), 4\u201314 (2018). https:\/\/doi.org\/10.1007\/s12020-018-1535-2","journal-title":"Endocrine"},{"issue":"11","key":"3790_CR38","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/jbmr.4682","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"J.P. Bilezikian, S.J. Silverberg, F. Bandeira et al. Management of primary hyperparathyroidism. J. Bone Min. Res 37(11), 2391\u20132403 (2022). https:\/\/doi.org\/10.1002\/jbmr.4682","journal-title":"J. Bone Min. Res"},{"issue":"2","key":"3790_CR39","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"J. Bollerslev, L. Rejnmark, A. Zahn et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. Eur. J. Endocrinol. 186(2), R33\u2013R63 (2022). https:\/\/doi.org\/10.1530\/EJE-21-1044","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03790-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T11:59:45Z","timestamp":1722427185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03790-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3790"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03790-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective review of previously published guidelines was deemed exempt from review by the University of Pennsylvania Health System Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}